Search Results - Luca Valenti

Refine Results
  1. 1
    A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

    A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia by Luca Valenti

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis

    The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis by Luca Valenti

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease

    Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease by Luca Valenti

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Telomeres, NAFLD and Chronic Liver Disease

    Telomeres, NAFLD and Chronic Liver Disease by Benedetta Donati, Luca Valenti

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease

    A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease by Paola Dongiovanni, Luca Valenti

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease

    Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease by Serena Pelusi, Luca Valenti

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Update on NAFLD genetics: From new variants to the clinic

    Update on NAFLD genetics: From new variants to the clinic by Eric Trépo, Luca Valenti

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Redefining fatty liver disease classification in 2020

    Redefining fatty liver disease classification in 2020 by Luca Valenti, Serena Pelusi

    Published 2020
    Get full text
    Carta
    Save to List
    Saved in:
  9. 9
    Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis

    Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis by Paola Dongiovanni, Stefano Romeo, Luca Valenti

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms

    Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms by Luca Valenti, Anna Alisi, Valério Nobili

    Published 2012
    Get full text
    Carta
    Save to List
    Saved in:
  11. 11
    Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes

    Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes by David Frescas, Luca Valenti, Domenico Accili

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Risk of Serious Bacterial and Non‐Bacterial Infections in People With <scp>MASLD</scp>

    Risk of Serious Bacterial and Non‐Bacterial Infections in People With <scp>MASLD</scp> by Giovanni Targher, Herbert Tilg, Luca Valenti

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Beyond hereditary hemochromatosis: New insights into the relationship between iron overload and chronic liver diseases

    Beyond hereditary hemochromatosis: New insights into the relationship between iron overload and chronic liver diseases by Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment by Paola Dongiovanni, Quentin M. Anstee, Luca Valenti

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease

    Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease by Stefano Romeo, Arun J. Sanyal, Luca Valenti

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Nutritional therapy for nonalcoholic fatty liver disease

    Nutritional therapy for nonalcoholic fatty liver disease by Paola Dongiovanni, Claudia Lanti, Patrizia Riso, Luca Valenti

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?

    The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target? by Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    COVID‐19 and liver disease

    COVID‐19 and liver disease by Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets

    Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets by Cristiana Bianco, Elia Casirati, Francesco Malvestiti, Luca Valenti

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date

    PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date by Alessandro Cherubini, Elia Casirati, Melissa Tomasi, Luca Valenti

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: